Vitamin D3-associated lyotropic liquid crystalline nanoparticles for gemcitabine and thymoquinone delivery for treatment of luminal breast cancer with resistant characteristics

Breast cancer is a leading cause of cancer death in women worldwide. About 70 – 80% of breast cancers are estrogen receptor-alpha (ERα) positive, dependent on estrogen for growth. Primary or acquired resistance towards endocrine therapy has remained a therapeutic barrier for patients in this subg...

詳細記述

書誌詳細

第一著者:	Loo, Yan Shan
フォーマット:	学位論文
言語:	英語
出版事項:	2023
主題:	Breast Neoplasms - Drug therapy Nanoparticles - Therapeutic use Drug Delivery Systems - Methods
オンライン･アクセス:	http://psasir.upm.edu.my/id/eprint/119037/1/119037.pdf